MAZE THERAPEUTICS, INC. (MAZE)

SEC filing

MAZE THERAPEUTICS, INC.

MAZE · CIK 1842295

4 · Feb 4, 2026 · Bachrodt Amy sold 5,000 shares at $46.04/share ($230.2K); exercised options for 5,000 shares

Bachrodt Amy sold 5,000 shares at $46.04/share ($230.2K); exercised options for 5,000 shares

xslF345X05/form4-02042026_090208.xml

xslF345X05/form4-02042026_090208.xmlSEC.gov

Graphics and non-inline formats (not embedded below).